Who we are?

Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private French pharmaceutical group. In 2016, it generated 2,282 million euros in revenues, of which 60% came from its international business and 57% from its dermo-cosmetics division. Pierre Fabre, which has always been headquartered in the South-West of France, owns subsidiaries and offices in 47 countries, enjoys distribution agreements in over 130 countries and counts more than 13,000 employees worldwide. 

Pierre Fabre’s portfolio represents a continuum of activities spanning from prescription drugs and consumer health care products to dermo-cosmetics. In 2016, Pierre Fabre dedicated almost 180 million euros to R&D, shared between oncology, the central nervous system, consumer health care, dermatology and dermo-cosmetics.

Up-close look into the Pierre Fabre Laboratories

We design and develop the most innovative and focused skin care solutions.
Medicalised products including toothpaste, mouthwash and teething gel.
The first oral chemotherapy drug developed using the Madagascar periwinkle flower

News